The Unreasonable Dangers Of Xarelto (Rivaroxaban)

Although the television commercial breaks and online communities are overflowing with lawsuits concerning bad drugs and the potential dangers they cause, one in particular caught our attention this year.

Bayer HealthCare released Xarelto in 2011 as a anticoagulant and hoped that it would replace Coumadin (warfarin), as a blood thinner that required significantly less labor and time intensive monitoring for patients with atrial fibrillation and those at risk for stroke. The drug was deemed safe by the FDA, but shortly after it started being prescribed a huge and unreasonable danger was brought to national attention.

Both Coumadin and Xarelto share the risk of bleed outs, i.e. when the drug that successfully prevents blood clots from forming within the body also prevents necessary clots from stopping bleeding out of the body. However, when this occurred with Coumadin a patient could be administered vitamin K which acted to reverse the effects of the drug and stop the bleeding, but Xarelto has no similar antidote and as such minor injuries can lead to catastrophic results including 151 deaths and 2,081 bleed out incidents within the first year.
If you or a loved one have been injured by Xarelto please contact us. We would like to help.